BC Children's is the province's only full-service, pediatric acute care hospital which serves 1 million kids in BC and the Yukon. Our research institute conducts discovery, translational and clinical research to save lives and transform child health. We’re part of the Provincial Health Services Authority and partners with BC Children's Hospital Foundation and the University of British Columbia.
Dr. Rebecca Deyell is a pediatric hematologist/oncologist with a research focus in pediatric oncogenomics, neuroblastoma, precision medicine trials for children and adolescents with cancer, and developmental therapeutics.
Dr. Deyell is interested in developing early phase clinical trials in pediatric oncology to facilitate the rapid transition of new, targeted drug therapies from the lab to the patient.
Clinical Assistant Professor, Department of Pediatrics, Faculty of Medicine, University of British Columbia
Dr. Kirk Schultz is a Pediatric Hematologist/Oncologist focused on new therapies and rejection in Blood and Marrow Transplantation (BMT) and immune therapy of blood cancers. Dr. Schultz is a past recipient of the CIHR/Wyeth Clinical Research Chair in Transplantation and a fellow of the Canadian Academy of Health Sciences.
Dr. Schultz’s research focuses on harnessing the immune forces unleashed by blood and marrow transplantation to improve immune therapy for childhood leukemia. By increasing understanding of these important immune forces, he hopes to improve the ability to provide safe transplants when neede
Professor, Division of Hematology and Oncology, Department of Pediatrics, University of British Columbia
Dr. Rod Rassekh’s research is in applying genomics in order to improve therapies for children with cancer. His main research focus is in pharmacogenomics of chemotherapy adverse outcomes – quantifying what complications are seen in cancer survivors and finding genetic markers that may identify those who are at higher risk of complications. His team has identified genetic markers of risk for heart failure and hearing loss due to chemotherapy. He is also leading a Personalized Oncogenomics study, which uses tumor genomics in order to find novel medications for treatment of relapsed cancer by looking at tumor DNA, RNA and proteins. Dr. Rassekh is a member of the development therapeutics team at BC Children’s Hospital.
Clinical Assistant Professor, Division of Oncology/ Hematology/ BMT, Department of Pediatrics, University of British Columbia
Dr. Caron Strahlendorf’s research is focused on the efficient and productive collection of stem cells with the goal to maximal harvest and surveillance of minimal residual disease. Of particular interest is research into processes that will allow maximal efficient cell harvest in very young children.
In collaboration with other onsite laboratories at BC Children’s Hospital, Dr. Strahlendorf hopes to explore the potential of product manipulation related to dendritic and cellular therapies.
Her interests extend to the issues highlighting cross-cultural care as well as the psychosocial issues that present to the patients and families within different cultural populations. Currently, she is investigating alternative or complimentary medical practices in the field of pediatric oncology.
Clinical Associate Professor, Division of Hematology and Oncology, Department of Pediatrics, University of British Columbia